Address: Insure Insights 61 Bridge Street, Kington.HR5 3DJ United Kingdom

Global Cardiac Biomarker Diagnostic Kits Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Home
  • Reports
  • Global Cardiac Biomarker Diagnostic Kits Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028
Global Cardiac Biomarker Diagnostic Kits Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

Global Cardiac Biomarker Diagnostic Kits Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Published Date: 01 Jun 2021
  • Report ID: HLT 00212
  • Pages:168
  • Base Year: 2019
  • Format: PDF
  • Historical Data: 2016-2019

Global Cardiac Biomarker Diagnostic Kits Market is anticipated to rise at a value CAGR of 4.75 % over 2019-2028. According to a study published by Insure Insights on the Global Cardiac Biomarker Diagnostic Kits Market. Cardiac Biomarker are generally endogenous products like enzymes, hormones released from heart during cardiac dysfunctions. These biomarkers help the healthcare professional to diagnose cardiac dysfunctions like myocardial infarction, acute coronary syndrome, etc. Government initiatives for better healthcare and the increasing funds from public-private organizations for research and development for better technology are expanding the market growth. The surge in Clinical trials for the identification of cardiac biomarkers for better diagnosis has boosted the market revenue.

Top Driver: The surge in Cardiovascular disorders around the globe are driving market growth.

The rise in the occurrence of Cardiovascular disorders, like myocardial infarction angina pectoris, etc. around the globe and lifestyle habits like smoking and consumption of alcohol are the primary factors driving the market growth. The surge in the elderly population and technological advancements in cardiac diagnosis, sophisticated healthcare infrastructure have propelled the growth of the market. The advent of POC diagnostics kits has further driven the growth of the market.

Troponin test kits have made the highest segmental growth in the Global Cardiac Biomarker Diagnostic Kits Market

Based on the Product, Troponin test kits segment have dominated the segmental growth as they are considered as the most sensitive test kit, and thus, they are mostly preferred by the medical professionals for the diagnosis of cardiovascular diseases. They are the most efficient and provide accurate diagnosis of cardiovascular disorders as compared with other products

   In terms of the Testing, POC diagnostics segment has obtained due to the rise in the demand for POC testing, especially in the developed countries, POC test kits are small, handy, and they are more convenient to use and thus have improved the market growth. Based on the End User, Hospitals segment have held the most significant growth due to the availability of advanced instruments for cardiac diagnosis, increase in the healthcare expenditure, and enhanced patient care in hospitals have further driven the market

North America boosts the regional market due to the presence of key players  

The presence of key players in the region has positively influenced the regional growth. The rise in the research and development activities by the players and government initiatives for cardiovascular diagnosis and treatments have enhanced the overall regional growth. The rise in the incidences of cardiac diseases, in the region, the presence of sophisticated health care infrastructure, and increase in health care expenditure have escalated the market growth.

Product launches, new innovations, Mergers, and Acquisition, are the key strategies of the competitors

The Players of the Global Cardiac Biomarker Diagnostic Kits Market is fragmented. Product launches, new innovations, Mergers, and Acquisition, are strategies used by the competitors   The key competitors of the Global Cardiac Biomarker Diagnostic Kits Market are Hoffmann-La Roche AG, Bio-Rad Laboratories, Danaher Corporation, Abbott Laboratories, Seimens Healthineers, Thermofisher Scientific, bioMérieux, Randox Laboratories Ltd., and Ortho Clinical Diagnostics.

Seimens Healthineers:  Seimens Healthineers, is one of the key competitors of the Global Cardiac Biomarker Diagnostic Kits Market; for instance, In July 2018, Seimens Healthineers, had announced that the he U.S. Food and Drug Administration (FDA) cleared Siemens Healthineers high-sensitivity troponin I assay (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. It was designed for early diagnosis of myocardial infarction.

Thermofisher Scientific:  Thermofisher Scientific is a popular competitor in the Global Cardiac Biomarker Diagnostic Kits Market. In March 2020, Boston Scientific Corporation had announced the acquisition of QIAGEN N.; they are involved in the manufacturing of the minimally invasive device. The acquisition was made by Thermofisher Scientific to expands its product portfolio with attractive molecular diagnostics capabilities, including infectious disease testing. 

Scope of the Report

By Product

  • Troponin test kits
  • CK-MB test kits
  • Other Test kits

By Testing

  • Laboratory testing
  • Point of care testing

By End User

  • Hospitals
  • Diagnostics centers
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • LAMEA

Key Reasons to Purchase this Report

  1. It provides a technological development map over time to understand the growth rate of the industry.
  2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
  3. It renders definite analysis for changing competitive dynamics.
  4. It builds a seven-year estimate based on how the market is predicted to grow.

Table of Content

Chapter 1           Overview And Scope

1.1             Market Vision

1.1.1          Market Definition

1.1.2          Market Scope

1.2             Market Segmentation

Chapter 2           Our Research Practice

2.1             Our Research Methodology

2.2             Data Triangulation

2.3             Data Sources

2.4             Assumptions for the study

2.5             Approach Adopted

Chapter 3           Executive Summary

3.1             Market Snapshot

3.2             Regional Snapshot

3.3             Segment Summary

Chapter 4           Covid-19 Impact Analysis

4.1             Overview

4.2             Prevalence analysis

4.3             Key Factor Impact Analysis

Chapter 5           Global Cardiac Biomarker Diagnostic Kits Market Forces

5.1             What’s Driving the Market

5.2             Porter’s Five Forces Analysis

5.2.1          Power of Suppliers

5.2.2          Threats From New Entrants

5.2.3          Power of Buyer

5.2.4          Threat From Substitute Product

5.2.5          Degree of Competition

Chapter 6           Global Cardiac Biomarker Diagnostic Kits Market -Industry Snapshots

6.1             Overview

6.1.1          Global Cardiac Biomarker Diagnostic Kits Market Value, 2019 – 2028, (US$ Bn)

6.2             Market Overview

6.2.1          Drivers Analysis

6.2.2          Restraint/Challenges analysis

6.2.3          Opportunity Analysis

6.3             Supply Chain/Value Chain Analysis

6.4             Market SWOT Analysis

Chapter 7           Global Cardiac Biomarker Diagnostic Kits Market Analysis, by Product

7.1             Overview

7.2             Key Findings for Cardiac Biomarker Diagnostic Kits Market- By Product

7.2.1          Cardiac Biomarker Diagnostic Kits Market- Troponin test kits

7.2.2          Cardiac Biomarker Diagnostic Kits Market- CK-MB test kits

7.2.3          Cardiac Biomarker Diagnostic Kits Market- Other test kits

Chapter 8           Global Cardiac Biomarker Diagnostic Kits Market Analysis, by Testing

8.1             Overview

8.2             Key Findings for Cardiac Biomarker Diagnostic Kits Market- By Testing

8.2.1          Cardiac Biomarker Diagnostic Kits Market-Laboratory testing

8.2.2          Cardiac Biomarker Diagnostic Kits Market- Point of care testing

Chapter 9           Global Cardiac Biomarker Diagnostic Kits Market Analysis, by End User

9.1             Overview

9.2             Key Findings for Cardiac Biomarker Diagnostic Kits Market- By End User

9.2.1          Cardiac Biomarker Diagnostic Kits Market- Hospitals

9.2.2          Cardiac Biomarker Diagnostic Kits Market- Diagnostics centers

9.2.3          Cardiac Biomarker Diagnostic Kits Market- Others

Chapter 10       Cardiac Biomarker Diagnostic Kits Market Analysis by Region

10.1           Key Findings for Cardiac Biomarker Diagnostic Kits Market- By region

10.2           Overview

10.2.1       Global Cardiac Biomarker Diagnostic Kits Market Analysis, By Product, 2019 – 2028

10.2.2       Global Cardiac Biomarker Diagnostic Kits Market Analysis, By Testing, 2019 – 2028

10.2.3       Global Cardiac Biomarker Diagnostic Kits Market Analysis, By End User , 2019 – 2028

10.3           Cardiac Biomarker Diagnostic Kits Market – North America

10.3.1       Overview

10.3.2       U.S.

10.3.3       Canada

10.3.4       Mexico

10.3.5       North America Market, By Product

10.3.6       North America Market, By Testing

10.3.7       North America Market, By End User

10.4           Cardiac Biomarker Diagnostic Kits Market – Europe

10.4.1       Overview

10.4.2       Germany

10.4.3       United Kingdom

10.4.4       France

10.4.5       Italy

10.4.6       Rest Of Europe

10.4.7       Europe Market, By Product

10.4.8       Europe Market, By Testing

10.4.9       Europe market by, End User

10.5           Cardiac Biomarker Diagnostic Kits Market – Asia Pacific

10.5.1       Overview

10.5.2       China

10.5.3       Japan

10.5.4       India

10.5.5       Rest of APAC

10.5.6       Asia Pacific Market, By Product

10.5.7       Asia Pacific Market, By Testing

10.5.8       Asia Pacific Market, By End User

10.6           Cardiac Biomarker Diagnostic Kits Market – LAMEA

10.6.1       Overview

10.6.2       Middle East & Africa (MEA)

10.6.3       Latin America

10.6.4       Rest Of World

10.6.5       Latin America, Middle East and Africa Market, By Product

10.6.6       Latin America, Middle East and Africa Market, By Testing

10.6.7       Latin America, Middle East and Africa Market, By End User

Chapter 11       Market Competition Analysis

11.1           Market Share/Positioning Analysis

11.1.1       Market Positioning of Key Vendors, 2019

11.1.2       Key Strategies Adopted by the Leading Players

11.1.3       Recent Developments

Chapter 12       Company Profiles- Snapshot

12.1           Hoffmann-La Roche AG

12.1.1       Business Fundamentals

12.1.2       Financial Snapshots

12.1.3       Product Portfolio

12.1.4       Recent Developments

12.2           Bio-Rad Laboratories

12.3           Danaher Corporation

12.4           Abbott Laboratories

12.5           Seimens Healthineers

12.6           Thermofisher Scientific

12.7           bioMérieux

12.8           Randox Laboratories Ltd.

12.9           Ortho Clinical Diagnostics

*More than 10 Companies are profiled in this Research Report*

*Financials would be provided on a best efforts basis for private companies”

Chapter 13       Appendix

 

 

 

Request for Sample

Please fill out the form to receive sample pages of the report